Imexon

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

Imexon

Clinical data
ATC code	none
Identifiers
IUPAC name 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
CAS Number	59643-91-3 Y
PubChem CID	68791
ChemSpider	62031 N
UNII	8F63U28T2V
KEGG	D08932 Y
CompTox Dashboard (EPA)	DTXSID1046895
ECHA InfoCard	100.056.199
Chemical and physical data
Formula	C4H5N3O
Molar mass	111.104 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1/N=C(/N)C2N1C2
InChI InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8) N Key:BIXBBIPTYBJTRY-UHFFFAOYSA-N N
NY (what is this?)  (verify)

References

• Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.